{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:49:55Z","timestamp":1786985395656,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjaed.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BJA Education"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bjae.2025.01.003","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T23:38:52Z","timestamp":1739921932000},"page":"206-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel therapies and interventions in sepsis and septic shock"],"prefix":"10.1016","volume":"25","author":[{"given":"A.","family":"Pisano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Venditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjae.2025.01.003_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.bjae.2025.01.003_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.23736\/S0031-0808.23.04986-8","article-title":"Beyond the Surviving Sepsis Campaign Guidelines: a systematic review of interventions affecting mortality in sepsis","volume":"66","author":"Sartini","year":"2024","journal-title":"Panminerva Med"},{"issue":"8 Pt B","key":"10.1016\/j.bjae.2025.01.003_bib4","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1053\/j.jvca.2022.04.005","article-title":"Four decades of randomized clinical trials influencing mortality in critically ill and perioperative patients","volume":"36","author":"Romero","year":"2022","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bjae.2025.01.003_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s13054-023-04755-5","article-title":"Positive single-center randomized trials and subsequent multicenter randomized trials in critically ill patients: a systematic review","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.bjae.2025.01.003_bib6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/CCM.0000000000006314","article-title":"Low versus high blood pressure targets in critically ill and surgical patients: a systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"D'Amico","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.chest.2023.04.036","article-title":"Lower vs higher fluid volumes in adult patients with sepsis: an updated systematic review with meta-analysis and trial sequential analysis","volume":"164","author":"Sivapalan","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.bjae.2025.01.003_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3855\/jidc.18489","article-title":"Use of inferior vena cava guided fluid therapy in the treatment of septic shock: a randomised controlled trial","volume":"18","author":"Ghosh","year":"2024","journal-title":"J\u00a0Infect Dev Ctries"},{"key":"10.1016\/j.bjae.2025.01.003_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.24908\/pocus.v8i1.15683","article-title":"The frequency of POCUS in the treatment of sepsis in the emergency department: a retrospective cohort study","volume":"8","author":"Dalla","year":"2023","journal-title":"POCUS J"},{"key":"10.1016\/j.bjae.2025.01.003_bib10","first-page":"163","article-title":"Mitral systolic anterior motion: beyond cardiology and cardiac surgery","volume":"24","author":"Venditto","year":"2024","journal-title":"ICU Manag Pract"},{"key":"10.1016\/j.bjae.2025.01.003_bib11","first-page":"1107","article-title":"The risk of infusing gelatin? Die-hard misconceptions and forgotten (or ignored) truths","volume":"82","author":"Pisano","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.bjae.2025.01.003_bib12","article-title":"Early albumin\u00a0infusion is associated with greater survival to discharge among patients with sepsis\/septic shock who develop severe acute kidney injury","volume":"5","author":"Raghunathan","year":"2023","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.bjae.2025.01.003_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12879-023-08147-6","article-title":"Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjae.2025.01.003_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s44158-024-00150-w","article-title":"Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review","volume":"4","author":"Coloretti","year":"2024","journal-title":"J\u00a0Anesth Analg Crit Care"},{"key":"10.1016\/j.bjae.2025.01.003_bib15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1213\/ANE.0000000000006682","article-title":"Renin as a prognostic marker in intensive care and perioperative settings: a scoping review","volume":"138","author":"Kotani","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bjae.2025.01.003_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.jvca.2023.09.037","article-title":"Methylene blue reduces mortality in critically ill and perioperative patients: a meta-analysis of randomized trials","volume":"38","author":"Pruna","year":"2024","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bjae.2025.01.003_bib17","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1053\/j.jvca.2023.04.006","article-title":"Hydroxocobalamin for vasodilatory hypotension in shock: a systematic review with meta-analysis for comparison to methylene blue","volume":"37","author":"Brokmeier","year":"2023","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bjae.2025.01.003_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","article-title":"High-dose IV hydroxocobalamin (vitamin B12) in septic shock: a double-blind, allocation-concealed, placebo-controlled single-center pilot randomized controlled trial (The Intravenous Hydroxocobalamin in Septic Shock Trial)","volume":"163","author":"Patel","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.bjae.2025.01.003_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MEJ.0000000000001105","article-title":"The association between levosimendan and mortality in patients with sepsis or septic shock: a systematic review and meta-analysis","volume":"31","author":"Ge","year":"2024","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fanes.2022.1115750","article-title":"Old issues and new challenges in cardiothoracic anesthesiology: work in progress\u2026","volume":"1","author":"Pisano","year":"2023","journal-title":"Front Anesthesiol"},{"key":"10.1016\/j.bjae.2025.01.003_bib21","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","article-title":"Levosimendan for the prevention of acute organ dysfunction in sepsis","volume":"375","author":"Gordon","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1053\/j.jvca.2017.11.039","article-title":"Ultra-short-acting \u03b2-blockers (esmolol and landiolol) in the perioperative period and in critically ill patients","volume":"32","author":"Poveda-Jaramillo","year":"2018","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bjae.2025.01.003_bib23","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.chest.2021.01.009","article-title":"Effect of ultrashort-acting \u03b2-Blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials","volume":"159","author":"Hasegawa","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.bjae.2025.01.003_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2023.20134","article-title":"Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical Trial","volume":"330","author":"Whitehouse","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bjae.2025.01.003_bib26","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","article-title":"Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP)","volume":"50","author":"Rehberg","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib27","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.hlc.2023.12.022","article-title":"Landiolol in septic shock - no one-size-fits-all approach","volume":"33","author":"Schnaubelt","year":"2024","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.bjae.2025.01.003_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/ACO.0000000000001206","article-title":"Is venoarterial extracorporeal membrane oxygenation an option for managing septic shock","volume":"36","author":"Helwani","year":"2023","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.bjae.2025.01.003_bib29","series-title":"Reducing mortality in critically ill patients","first-page":"33","article-title":"Restrictive inspiratory oxygen fraction","author":"Pisano","year":"2021"},{"key":"10.1016\/j.bjae.2025.01.003_bib30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bjae.2023.09.001","article-title":"Empirical decision-making for antimicrobial therapy in critically ill patients","volume":"23","author":"Ippolito","year":"2023","journal-title":"BJA Educ"},{"key":"10.1016\/j.bjae.2025.01.003_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.chest.2021.06.029","article-title":"Antibiotic timing and progression to septic shock among patients in the ED with suspected infection","volume":"161","author":"Bisarya","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.bjae.2025.01.003_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.2023.10598","article-title":"MERCY Investigators. Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial","volume":"330","author":"Monti","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bjae.2025.01.003_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2024.9779","article-title":"BLING III Study Investigators. Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial","volume":"332","author":"Dulhunty","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.bjae.2025.01.003_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13054-023-04602-7","article-title":"IDEAL-ICU Study. Differential effect on mortality of the timing of initiation of renal replacement therapy according to the criteria used to diagnose acute kidney injury: an IDEAL-ICU substudy","volume":"27","author":"Barbar","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.bjae.2025.01.003_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13054-022-03955-9","article-title":"Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies","volume":"26","author":"Gaudry","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.bjae.2025.01.003_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","article-title":"APROCCHSS investigators; CRICS-TRIGGERSEP network. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial","volume":"12","author":"Heming","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib37","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/CCM.0000000000006161","volume":"52","author":"Lai","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/CCM.0000000000006171","article-title":"Executive summary: guidelines on use of corticosteroids in critically ill patients with sepsis, acute respiratory distress syndrome, and community-acquired pneumonia focused update 2024","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib39","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3760\/cma.j.issn.0366-6999.20121880","article-title":"Body temperature control in patients with refractory septic shock: too much may be harmful","volume":"126","author":"Yang","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bjae.2025.01.003_bib40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/CCM.0000000000005470","article-title":"Therapeutic hyperthermia is associated with improved survival in afebrile critically ill patients with sepsis: a pilot randomized trial","volume":"50","author":"Drewry","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib41","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/CCM.0000000000004364","article-title":"Therapeutic hypothermia in critically ill patients: a systematic review and meta-analysis of high quality randomized trials","volume":"48","author":"Kim","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib42","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving sepsis campaign management guidelines Committee. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2264318","article-title":"Anisodamine hydrobromide in the treatment of critically ill patients with septic shock: a multicenter randomized controlled trial","volume":"55","author":"Zhang","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.bjae.2025.01.003_bib44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2403769","article-title":"A\u00a0randomized trial of intravenous amino\u00a0acids for kidney protection","volume":"391","author":"Landoni","year":"2024","journal-title":"N\u00a0Engl J Med"}],"container-title":["BJA Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2058534925000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2058534925000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:33:46Z","timestamp":1777624426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2058534925000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2058534925000071"],"URL":"https:\/\/doi.org\/10.1016\/j.bjae.2025.01.003","relation":{},"ISSN":["2058-5349"],"issn-type":[{"value":"2058-5349","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel therapies and interventions in sepsis and septic shock","name":"articletitle","label":"Article Title"},{"value":"BJA Education","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjae.2025.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}